Stephanie Gachet

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

CEBP and ZEB2 alterations define three distinct subtypes of B-cell acute lymphoblastic leukemia.

CEBP and ZEB2 alterations define three distinct subtypes of B-cell acute lymphoblastic leukemia.

Journal: HemaSphere
Published: February 01, 2026

Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia.

Modeling the PAX5P80R Mutation Reveals HIF2α Activation as a Common Feature and Therapeutic Target in B-cell Acute Lymphoblastic Leukemia.

Journal: Cancer research
Published: May 21, 2024

Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.

Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.

Journal: Blood cancer discovery
Published: September 21, 2022

Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.

Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.

Journal: Cell stem cell
Published: April 22, 2022

Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.

Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.

Journal: Blood
Published: January 04, 2022

Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy.

Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy.

Journal: Cancer discovery
Published: February 08, 2021

NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.

NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.

Journal: PloS one
Published: February 02, 2021

A Tumor Suppressor Enhancer of PTEN in T-cell development and leukemia.

A Tumor Suppressor Enhancer of PTEN in T-cell development and leukemia.

Journal: Blood cancer discovery
Published: January 18, 2021

Large-scale circular RNA deregulation in T-ALL: unlocking unique ectopic expression of molecular subtypes.

Large-scale circular RNA deregulation in T-ALL: unlocking unique ectopic expression of molecular subtypes.

Journal: Blood advances
Published: May 13, 2020

BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias.

BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias.

Journal: Leukemia research
Published: September 18, 2019

Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation.

Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation.

Journal: Cancer discovery
Published: July 30, 2017

Biallelic inactivation of REV7 is associated with Fanconi anemia.

Biallelic inactivation of REV7 is associated with Fanconi anemia.

Journal: The Journal of clinical investigation
Published: March 02, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026